ストックスクリーナーアプリを入手
40.71
1.76%
-0.73
前日終値:
$41.44
開ける：
$40.67
24時間の取引高:
1.73M
Relative Volume:
1.32
時価総額：
$9.15B
収益：
$1.97B
当期純損益:
$92.93M
株価収益率:
100.12
EPS:
0.4066
ネットキャッシュフロー:
$459.60M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
+2.24%
6か月 パフォーマンス:
-7.29%
1年 パフォーマンス:
+0.89%
1日の値動き範囲:
$40.00
$41.12
1週間の範囲:
$40.00
$43.88
52週間の値動き範囲:
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
QGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
40.71 | 9.15B | 1.97B | 92.93M | 459.60M | 0.4066 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen’s Voting Rights Announcement Involves Major Financial Entities - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Fivespan Is Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen's Future Under The Microscope After Stake Purchase - Finimize
Fivespan Partners Positions Itself in Qiagen (QGEN) Amid Activis - GuruFocus
Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake - marketscreener.com
Activist investor Fivespan takes stake in QiagenBloomberg (QGEN:NYSE) - Seeking Alpha
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - 01net
QIAGEN's Lab Revolution: New Automation Systems Promise 3x Faster Sample Processing - Stock Titan
Qiagen (QGEN) Target Price Reduced Amid Negative Market Sentimen - GuruFocus
BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating - MarketScreener
QIAGEN Announces Voting Rights Notification by AFM - TipRanks
Qiagen gains after guidance raise - MSN
Qiagen Announces Change in Total Voting Rights - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - sharewise.com
QIAGEN Earnings Alert: Key Q1 2025 Results Coming May 7What to Watch - Stock Titan
Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted -- Shares Rise - MarketScreener
Qiagen stock gains after guidance raise (QGEN:NYSE) - Seeking Alpha
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance - Benzinga
Qiagen: Q1 beat; profitability guidance upgraded - MarketScreener
QIAGEN NV : Deutsche Bank maintains a Buy rating - marketscreener.com
QIAGEN NV : UBS gives a Neutral rating - MarketScreener
Qiagen the only DAX stock to risehigher profit forecast helps - MarketScreener
QIAGEN NV : Jefferies gives a Buy rating - MarketScreener
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook - Yahoo Finance
EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook - sharewise.com
QIAGEN Crushes Q1 Targets: Key Products Surge, EPS Guidance Raised to $2.35 - Stock Titan
Qiagen Says Q1 Adjusted EPS $0.55 - MarketScreener
QIAGEN Smashes Q1 Targets: 7% Growth Powers Confident 2025 Outlook Boost - Stock Titan
Redburn Atlantic Downgrades Qiagen N.V. (BIT:1QGEN) - Nasdaq
Redburn Atlantic Downgrades Qiagen N.V. (LSE:0RLT) - Nasdaq
Qiagen Announces Voting Rights Update with Bank of America - TipRanks
Redburn cuts QIAGEN stock rating, lowers price target to EUR41 - Investing.com
Redburn cuts QIAGEN stock rating, lowers price target to EUR41 By Investing.com - Investing.com Australia
Redburn-Atlantic Downgrades QIAGEN NV (QIA:GR) (QGEN) to Neutral - StreetInsider
Lab Automation Market Top PlayersF. Hoffmann-La Roche, Qiagen - openPR.com
Qiagen introduces QIAprep Plasmodium kit to strengthen malaria research efforts - BioSpectrum Asia
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts - BioSpace
Revolutionary Malaria Test Kit: QIAGEN's New Solution Detects 5 Species with Single-Parasite Sensitivity - Stock Titan
QIAGEN N.V. Files 2024 Annual Report with SEC - TipRanks
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results - DutchNews.nl
PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
大文字化:
|
ボリューム (24 時間):